                               SEQUENCE LISTING

<110> FLAGSHIP PIONEERING INNOVATIONS VI, LLC
 
<120> COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN 
      MODULATION AND USES THEREOF

<130> 55503-714.601

<140> PCT/US2021/015746
<141> 2021-01-29

<150> 62/967,544
<151> 2020-01-29

<160> 26    

<170> PatentIn version 3.5

<210> 1
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="His" or " "

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Gly" or " "

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Val" or "Ile" or "Ser" or "Met"

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations
      for variant positions"

<400> 1
Gly Asp Asp Glu Xaa Asn Pro Gly Pro 
1               5                   


<210> 2
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Ile"

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any amino acid

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations
      for variant positions"

<400> 2
Asp Val Glu Xaa Asn Pro Gly Pro 
1               5               


<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Gly Asp Val Glu Ser Asn Pro Gly Pro 
1               5                   


<210> 4
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Gly Asp Ile Glu Glu Asn Pro Gly Pro 
1               5                   


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Val Glu Pro Asn Pro Gly Pro 
1               5           


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Ile Glu Thr Asn Pro Gly Pro 
1               5           


<210> 7
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Gly Asp Ile Glu Ser Asn Pro Gly Pro 
1               5                   


<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 8
Gly Asp Val Glu Leu Asn Pro Gly Pro 
1               5                   


<210> 9
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 9
Gly Asp Ile Glu Thr Asn Pro Gly Pro 
1               5                   


<210> 10
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Gly Asp Val Glu Asn Pro Gly Pro 
1               5               


<210> 11
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 11
Gly Asp Val Glu Glu Asn Pro Gly Pro 
1               5                   


<210> 12
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 12
Gly Asp Val Glu Gln Asn Pro Gly Pro 
1               5                   


<210> 13
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 13
Ile Glu Ser Asn Pro Gly Pro 
1               5           


<210> 14
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 14
Gly Asp Ile Glu Leu Asn Pro Gly Pro 
1               5                   


<210> 15
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 15
His Asp Ile Glu Thr Asn Pro Gly Pro 
1               5                   


<210> 16
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 16
His Asp Val Glu Thr Asn Pro Gly Pro 
1               5                   


<210> 17
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 17
His Asp Val Glu Met Asn Pro Gly Pro 
1               5                   


<210> 18
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 18
Gly Asp Met Glu Ser Asn Pro Gly Pro 
1               5                   


<210> 19
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 19
Gly Asp Val Glu Thr Asn Pro Gly Pro 
1               5                   


<210> 20
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 20
Gly Asp Ile Glu Gln Asn Pro Gly Pro 
1               5                   


<210> 21
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 21
Asp Ser Glu Phe Asn Pro Gly Pro 
1               5               


<210> 22
<211> 90
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 22
cgggucggca uggcaucucc accuccucgc gguccgaccu gggcauccga aggaggacgc       60

acguccacuc ggauggcuaa gggagagcca                                        90


<210> 23
<211> 88
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 23
uggccggcau ggucccagcc uccucgcugg cgccggcugg gcaacauucc gaggggaccg       60

uccccucggu aauggcgaau gggaccca                                          88


<210> 24
<211> 51
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 24
ucauaaucaa uuuauuauuu ucuuuuauuu uauucacaua auuuuguuuu u                51


<210> 25
<211> 19
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 25
auuuuguuuu uaacauuuc                                                    19


<210> 26
<211> 70
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 26
ucauaaucaa uuuauuauuu ucuuuuauuu uauucacaua auuuuguuuu uauuuuguuu       60

uuaacauuuc                                                              70


